Roshan Kumar retweeted
"Ramble On" is 56 years old and Robert Plant just walked onto The Late Show and made it sound like he wrote it this morning.
Roshan Kumar retweeted
This seems really bad but also like it was exactly the goal of systematically dismantling our federal government's standards & protections.
Roshan Kumar retweeted
"Perhaps the media is avoiding details in part because editors feel that talking about poop is distasteful. Even so, it’s clear that there’s a double standard at work." publicnotice.co/p/trump-poop…
Roshan Kumar retweeted
Don't forget to register for our Community Symposium on the Molecular Basis of ME/CFS, TOMORROW on zoom! 8am-2:30pm PST Attendance limited to 5,000. Registration required and can’t be shared. It will be recorded. Registration link: stanford.zoom.us/webinar/reg…
Roshan Kumar retweeted
Join us for an update from the PIs & patient reps on the projects funded by the @patientled research fund!
I'm a rep on the microbial metabolites one & the foraminal stenosis one.
@ahandvanish @Rivkatweets @SelinLab @MichaelPelusoMD @roshankumar @chiluvs1 @leticiasaurus & more
Roshan Kumar retweeted
"The administration has terminated more than 80% of USAID grants.
"A BU global health professor estimated these cuts have already resulted in about 300,000 deaths, most of them of children.
"That is what Musk’s foray into politics accomplished."
nytimes.com/2025/05/30/opini…
Roshan Kumar retweeted
Solving the "replication crisis" is dumb because (1) it's not a crisis, (2) the medicine is worse than the disease. Much of this is because people want science to be more like engineering, and it's not. It's fundamentally different and trying to treat engineering processes like scientific ones is going to turn out poorly.
I came into biology during the late 90's, when systems bio was taking off. Biologists aren't quantitative enough, and therefore we physicists, mathematicians, engineers, computer scientists will show you how it's done. Made lots of models of various processes such as immune responses to stress/insults.
None of them worked in retrospect. Not because the the math or code were wrong. The models themselves were missing key players that we didn't learn about until later. So the field as a whole was wrong (but again all replicable). How would one know that?
More recently, we've been working on a small molecule corrector of p53. We went through all the patents and literature. Almost all of it was wrong when we put everything across a fixed set of assays/cell types. It's not that these papers were all non-replicable, it was just a small part of a bigger picture that those papers didn't have. That's the generous conclusion, the not-so-generous one is that people are just crafting the best story they can, and will often explain away or just not do a negative result.
The problem isn't replicability, it's actually that most scientific results are likely lacking context, don't generalize, and are wrong in the more general sense of the word. There is a range of truth-seeking in practitioners, and it's true the most rigorous truth-seekers aren't always rewarded, but again, this is not something new. That's always been true in science, and well described in book's like Kuhn's Structure of Scientific Revolutions.
The potential solutions involve replication studies and publishing negative results. These things won't help the broader and more general problem. People want this the scientific process to be a very linear path full of incremental improvements that suddenly lead to a change. It's not how it works.
Roshan Kumar retweeted
Next week, we are hosting an international scientific workshop focused on the pathogenesis of #LongCovid at @YaleMed. Please join us on May 15th to learn about what we know and what we need to investigate next to get to the root causes ⏩ therapies 👇🏼👇🏼 @YaleCII
Roshan Kumar retweeted
"The crowd chants 'Don’t take the mother!' over and over again as the daughter keeps trying to get back on the hood of the car. More Worcester cops arrive, all helping the ICE agents carry out their rotten senseless work." ow.ly/QOqY50VQsLh
Roshan Kumar retweeted
Why test #celltherapies one-by-one when you can use multiplexed #SynBio, #proteinengineering & #ML to design, measure & track them at scale?
The Goodman Lab @PennMedicine opens July 2025. We’re hiring Specialists & Postdocs!
Apply @ bit.ly/42BnJNJ
RTs appreciated!🙏
Roshan Kumar retweeted
Wall Street Journal: 'How to Lead a Chronic Disease Revolution'
'Washington has an opportunity to help tens of millions'
By Akiko Iwasaki & Harlan Krumholz
'Millions of Americans struggle with debilitating fatigue, cognitive difficulties...'
wsj.com/opinion/how-to-lead-…
Roshan Kumar retweeted
Tomorrow at 6pm ET:
Webinar on PLRC-funded research on Immune Dysfunction & T-Cell exhaustion in LC and ME/CFS, done by UMass Chan Med School & HiFiBio.
Sign up:
ow.ly/4Spj50VumTk
Details:
solvecfs.org/event/investiga… #LongCovid @Rivkatweets @patientled
Roshan Kumar retweeted
“ I want to tell you powerlessness is an alibi. Hopelessness too. I want to ask, what specifically are you going to do?” Please please read this by one of my fav writers, Kaveh Akbar for The Nation
thenation.com/article/activi…
Roshan Kumar retweeted
Interested in single cell genomics but need help getting started? Check out my lab's Single Cell Genomics Day on April 25. Talks will feature recent exciting computational and experimental advances and will be live-streamed at satijalab.org/scgd. Please RT/spread the word!
Roshan Kumar retweeted
LeBron James:
“You can literally watch a game on mute and then play music at the same time and you can see the cadence of how someone dribbles or how someone moves.” 🎵🗣️
(via @ClutchPoints)
Roshan Kumar retweeted
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases.
I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known.
People can contact me directly at my first name (as written in my profile) at octant.bio.
Saying a prayer for my hometown 😢
Bad Religion - Los Angeles Is Burning youtu.be/BxoD9zWY9Rg?si=TBAh… via @YouTube
2
195
Roshan Kumar retweeted
( #Boston, MA, USA)
Research subjects sought for @MBVanElzakker ME/CFS Research Study at Mass. General Brigham
From the #Massachusetts ME/CFS & FM Association
massmecfs.org/newsletters/91…
#MEcfs #CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome

ALT ME/CFS Research Study at Mass. General Brigham Dr. Michael Van Elzakker's group at Mass. General Brigham is seeking participants in the Greater Boston Area who have been clinically diagnosed with ME/CFS for a new study of blood samples for coagulation factors and proteins. The study will also collect saliva samples and perform a pupillometry exam (reaction of pupils to light). The samples can be collected at home and participants will receive $20 in compensation. For more information, contact [email protected].


























